Risks for multidrug-resistant pathogens in the ICU

Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis

(2014) Yu-Chung Chuang et al.   BMC INFECTIOUS DISEASES

Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study

(2014) Jordi Vallés et al.   INTENSIVE CARE MEDICINE

A Multidisciplinary Intervention to Reduce Infections of ESBL- and AmpC-Producing, Gram-Negative Bacteria at a University Hospital

(2014) Jenny Dahl Knudsen et al.   PLoS One

Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit

(2014) Jean-Louis Vincent et al.   Lancet Respiratory Medicine

Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia

(2013) Yuichiro Shindo et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pseudomonas aeruginosaVentilator-associated Pneumonia. Predictive Factors of Treatment Failure

(2013) Benjamin Planquette et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

(2013) Julio Ramirez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

(2013) José Garnacho-Montero et al.   CHEMOTHERAPY

Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors

(2013) Ignacio Martin-Loeches et al.   INTENSIVE CARE MEDICINE

Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients

(2013) Mario Tumbarello et al.   INTENSIVE CARE MEDICINE

Evolution of interventional vancomycin trials in light of new antibiotic development in the USA, 1999–2012

(2013) Tian Yu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA

(2013) Timothy R. Pasquale et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Antibiotics in the clinical pipeline in 2013

(2013) Mark S Butler et al.   JOURNAL OF ANTIBIOTICS

Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality

(2013) Eric J. Ley et al.   JOURNAL OF SURGICAL RESEARCH

Antibiotic resistance—the need for global solutions

(2013) Ramanan Laxminarayan et al.   LANCET INFECTIOUS DISEASES

Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case–control study

(2013) Eva Polverino et al.   THORAX

A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of aPseudomonas aeruginosahybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers

(2013) Kerstin Westritschnig et al.   Human Vaccines & Immunotherapeutics

Antimicrobial Stewardship at a Large Tertiary Care Academic Medical Center: Cost Analysis Before, During, and After a 7-Year Program

(2012) Harold C. Standiford et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial

(2012) Christian van Delden et al.   INTENSIVE CARE MEDICINE

Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care-Associated Pneumonia: A UK Cohort Study

(2011) J. D. Chalmers et al.   CLINICAL INFECTIOUS DISEASES

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia

(2011) Michael S. Niederman et al.   INTENSIVE CARE MEDICINE

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study

(2011) Daniel H Kett et al.   LANCET INFECTIOUS DISEASES

Validation of the American Thoracic Society–Infectious Diseases Society of America Guidelines for Hospital‐Acquired Pneumonia in the Intensive Care Unit

(2010) Miquel Ferrer et al.   CLINICAL INFECTIOUS DISEASES

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

(2010) E. Rubinstein et al.   CLINICAL INFECTIOUS DISEASES

Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units

(2010) Despoina Koulenti et al.   CRITICAL CARE MEDICINE

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia

(2010) Antonio T. Freire et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

New Lipoglycopeptides

(2010) George G. Zhanel et al.   DRUGS

Efficacy Profiles of Daptomycin for Treatment of Invasive and Noninvasive Pulmonary Infections with Streptococcus pneumoniae

(2009) S. Henken et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany

(2009) E. De Cock et al.   INFECTION

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES